Synthesis, receptor binding activity and fluorescence property of fluorescent enkephalin analogs containing L-1-pyrenylalanine.
The novel fluorescent amino acid, L-1-pyrenylalanine (L-Pya), was prepared by the asymmetric hydrogenation of cyclic dehydrodipeptide. Fluorescent enkephalins containing one or two Pya residues at position 1,4 or 5 of [D-Ala2, Leu5]enkephalin were synthesized by the solution method. Mono-Pya-enkephalins showed strong fluorescence intensities and potent binding affinities with specificity and selectivity for opiate receptors. However, di-Pya-enkephalins showed markedly decreased receptor binding affinities. These results indicate that the incorporation of two Pya residues into enkephalin makes the peptide unable to interact with the opiate receptors, although introduction of one Pya residue is effective to elicit a specific receptor interaction. Di-Pya-enkephalins showed intramolecular excimer spectra, indicating that the peptides are able to take possible folded conformations.
Mihara
H
H
Laboratory of Biochemistry, Faculty of Science, Kyushu University, Fukuoka, Japan.
Lee
S
S
Shimohigashi
Y
Y
Aoyagi
H
H
Kato
T
T
Izumiya
N
N
Costa
T
T
D000818:Animals; D001667:Binding, Competitive; D001921:Brain / Q000378:metabolism*; D020875:Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; D004743:Enkephalin, Leucine / Q000031:analogs & derivatives / Q000493:pharmacokinetics; D016308:Enkephalin, Leucine-2-Alanine; D004745:Enkephalins / Q000138:chemical synthesis* / Q000493:pharmacokinetics; D005456:Fluorescent Dyes; D008566:Membranes / Q000378:metabolism; D008968:Molecular Conformation; D011721:Pyrenes / Q000138:chemical synthesis* / Q000493:pharmacokinetics; D051381:Rats; D011957:Receptors, Opioid / Q000378:metabolism*; D013050:Spectrometry, Fluorescence
D004745:Enkephalins; D005456:Fluorescent Dyes; D011721:Pyrenes; D011957:Receptors, Opioid; D020875:Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; D004743:Enkephalin, Leucine; D016308:Enkephalin, Leucine-2-Alanine